article thumbnail

OLCC Creates Podcast Focusing on Oversight of Oregon’s Recreational Marijuana Industry

Cannabis Law Report

Episode Four of “In the Weeds” focuses on the THC vaping respiratory illness crisis and Oregon’s ban on flavored THC vaping products. “In Portland, OR — The Oregon Liquor Control Commission has published the latest episode of its occasional podcast, “In the Weeds – The Ultimate OLCC Potcast.”

article thumbnail

NEW Proposition 65 Cannabis Regulations

Canna Law Blog

In addition, oils, wax, vapes, etc. There are eight pages of new regulation for cannabis businesses to digest. These safe harbors are key because, while voluntary, they represent a business’s de facto compliance with Prop. usually contain at least one chemical on OEHHA’s list. 65 Cannabis Regulations.

Vaping 70
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Different Types of Medical Marijuana Products: Your Complete Guide

MMJ Recs

Medical marijuana capsules also offer a familiar and convenient ingestion method, resembling traditional pharmaceuticals, which can enhance patient comfort and compliance. This method bypasses the digestive system and liver, resulting in a more consistent and controlled release of therapeutic compounds.

article thumbnail

California: Review- Kanha CMS Works Wonders With METRC

Cannabis Law Report

However, we had one today, and are still attempting to digest it. We spend most of our time working in the commercial cannabis industry in California – complaints about the complexity of licensing, tax reporting and regulatory compliance are constant. Vape Cartridges, Syringes, etc.). Perhaps we have become jaded.

article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

FDA has determined that your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d). Unapproved New and Misbranded Human Drug Products.

CBD 51